Akanda (AKAN) - 81.25% Below 52-Week High: Buy or Wait?

Stock Details

Akanda Corp (AKAN), a prominent company in the healthcare sector within the drug manufacturers - specialty & generic industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $22.70. Over the past 52 weeks, it has ranged between $2.30 and $121.06. This places the current price at 18.8% of its 52-week high and 888.2% above its 52-week low. Recent trading volume was recorded at 2,616. The 14-day Relative Strength Index (RSI) stands at 53.12, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $12.80 by 77.34%. Similarly, it is below its 200-day moving average of $31.76 by 28.53%. The MACD histogram is -2.20, indicating bearish momentum (MACD Line: 1.45, Signal Line: 3.65).

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

0.04

Below market average

Price to Book

2.34

EV/EBITDA

-0.80

EPS (TTM)

$696.80

Price to Sales

16.71

Beta

14.61

More volatile than market

Q:How is AKAN valued relative to its earnings and growth?

Akanda Corp trades at a P/E ratio of 0.04, which is below the market average of approximately 20. This lower valuation could indicate the market has modest growth expectations, or it might represent an undervalued opportunity if the fundamentals are strong.

Q:What is AKAN's risk profile compared to the market?

With a beta of 14.61, Akanda Corp is significantly more volatile than the market. For every 10% market move, this stock tends to move 146% in the same direction. Higher beta stocks offer greater potential returns but with increased risk. The price-to-book ratio of 2.34 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

-266.30%

Operating Margin

-443.80%

EBITDA

$-3,678,018

Return on Equity

-60.90%

Return on Assets

-28.70%

Revenue Growth (YoY)

21.90%

Earnings Growth (YoY)

0.00%

Q:How profitable and efficient is AKAN's business model?

Akanda Corp achieves a profit margin of -266.30%, meaning it retains $-266.30 from every $100 in revenue after all expenses. This relatively low margin suggests the company operates in a competitive environment or high-cost industry where profitability is challenging. The operating margin of -443.80% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at -60.90% and ROA at -28.70%, the company achieves moderate returns on invested capital.

Q:What are AKAN's recent growth trends?

Akanda Corp's revenue grew by 21.90% year-over-year, representing robust expansion that significantly outpaces typical market growth rates. This strong top-line performance suggests the company is successfully capturing market share or benefiting from favorable industry trends.0 These growth metrics should be evaluated against DRUG MANUFACTURERS - SPECIALTY & GENERIC industry averages for proper context.

Company Size & Market

Market Cap

$14.0M

Revenue (TTM)

$836,660

Revenue/Share (TTM)

$31.12

Shares Outstanding

534.42K

Book Value/Share

$102.00

Asset Type

Common Stock

Q:What is AKAN's market capitalization and position?

Akanda Corp has a market capitalization of $14.0M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 534.42K shares outstanding, the company's ownership is relatively concentrated. As a participant in the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry, it competes with other firms in this sector.

Q:How does AKAN's price compare to its book value?

Akanda Corp's book value per share is $102.00, while the current stock price is $22.70, resulting in a price-to-book (P/B) ratio of 0.22. Trading below book value can indicate the market perceives challenges ahead, or it might represent a value opportunity if the assets are quality and earnings can recover. Value investors often screen for P/B ratios below 1.0. As a common stock, this represents equity ownership with voting rights.

Fundamentals last updated: May 22, 2026, 02:16 AM

Technical Indicators

RSI (14-day)

53.12

Neutral

50-Day Moving Average

$12.80

77.34% above MA-50

200-Day Moving Average

$31.76

-28.53% below MA-200

MACD Line

1.45

MACD Signal

3.65

MACD Histogram

-2.20

Bearish

Q:What does AKAN's RSI value tell investors?

The RSI (Relative Strength Index) for AKAN is currently 53.12, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being above the 50-day moving average, this confirms bullish conditions.

Q:How should traders interpret AKAN's MACD and moving average crossovers?

MACD analysis shows the MACD line at 1.45 below the signal line at 3.65, with histogram at -2.20. This bearish crossover indicates downward pressure. The wide histogram confirms strong momentum. The 50-day MA ($12.80) is below the 200-day MA ($31.76), forming a death cross pattern that often warns of extended weakness. Price is currently between the MAs, suggesting transition.

Indicators last updated: May 22, 2026, 12:27 PM

Akanda Corp (AKAN) Stock